First HER2 directed medicine approved for patients with gastric cancer in a decade TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) ...
Enhertu is a targeted cancer therapy that’s used to treat different types of breast, lung, and stomach cancer in adults. It’s given as an IV infusion once every 3 weeks. Common side effects of Enhertu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results